Demographics (1)
- AGE_GRP - Subject age group at diagnosis (phv00420508.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Affection status of subject (phv00420503.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00420509.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte type (phv00420515.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00420514.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00420502.v1.p1)
- GLEASON_GRP - Gleason score group (phv00420512.v1.p1)
- IS_TUMOR - Tumor status (phv00420516.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00420517.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00420518.v1.p1)
- PSA_GRP - Diagnositc PSA level group (phv00420511.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00420513.v1.p1)
- SAMPLE_ID - Sample ID (phv00420505.v1.p1)
- SAMPLE_USE - Sample Use (phv00420506.v1.p1)
- STAGE_DISEASE - Pathological stage of disease (phv00420510.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00420507.v1.p1)
- SUBJECT_ID - Subject ID (phv00420501.v1.p1)
- SUBJECT_ID - Subject ID (phv00420504.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00420519.v1.p1)